Patents Assigned to Biolinq Incorporated
  • Patent number: 12109032
    Abstract: A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein. A microneedle-based electrochemical biosensors structure comprises a substrate, a microneedle biosensor, a primary electrically conductive element, a secondary electrically conductive element and an electrically insulative annular barrier.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: October 8, 2024
    Assignee: Biolinq Incorporated
    Inventors: Joshua Windmiller, James Patrick McCanna, Jared Rylan Tangney
  • Patent number: 12070313
    Abstract: Aspects of the current subject matter are directed to a sensor assembly of an analyte monitoring device including one or more microneedle arrays. Aspects are directed to components and architecture of a sensor assembly to implement power and processing aspects of a microneedle array-based continuous analyte monitoring device for the detection and measuring of an analyte. A source of a power-on event is determined, and the analyte monitoring device is transitioned to a mode that corresponds to the determined source. When a power-on event is determined to be a valid power-on event, the analyte monitoring device is transition to a mode that corresponds to a type of the valid power-on event.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: August 27, 2024
    Assignee: Biolinq Incorporated
    Inventors: Daniel Alonso-Soski, Anderson Micu, Yan Li, Christopher Griffith, Jennifer Ruth Walters Fuchs
  • Patent number: 12011294
    Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.
    Type: Grant
    Filed: December 21, 2022
    Date of Patent: June 18, 2024
    Assignee: Biolinq Incorporated
    Inventors: Alan Campbell, Sirilak Sattayasamitsathit, Jared Rylan Tangney, Thomas Arnold Peyser, Joshua Ray Windmiller
  • Patent number: 11986614
    Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
    Type: Grant
    Filed: April 25, 2023
    Date of Patent: May 21, 2024
    Assignee: Biolinq Incorporated
    Inventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
  • Patent number: 11963796
    Abstract: A skin-adorned physiological or biochemical sensing device is disclosed herein. The device preferably comprises a first substrate and a second substrate. The first substrate comprises an array of solid microneedles designed to penetrate a biological interface to access a physiological fluid or tissue. Each microneedle is capable of electrical interface with the physiological fluid or tissue. The second substrate comprises integrated circuitry designed to transduce at least one signal produced by an electrophysiological or electrochemical reaction. A sensing device is formed that is capable of interpreting the signal arising from the electrophysiological or electrochemical reaction to ascertain the level of some physiological or biochemical entity.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: April 23, 2024
    Assignee: Biolinq Incorporated
    Inventors: Joshua Windmiller, Jared Rylan Tangney
  • Patent number: 11904127
    Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
    Type: Grant
    Filed: April 25, 2023
    Date of Patent: February 20, 2024
    Assignee: Biolinq Incorporated
    Inventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
  • Patent number: 11872055
    Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: January 16, 2024
    Assignee: Biolinq Incorporated
    Inventors: Jared Rylan Tangney, Joshua Ray Windmiller, Richard Chien Yang
  • Patent number: 11857344
    Abstract: Fault detection and diagnostics for a microneedle array based continuous analyte monitoring device are provided. The electrochemical sensors, including the electrodes of the analyte monitoring device configured for measuring one or more target analytes, may experience various faults during use of the analyte monitoring device. By modeling the sensors as an electrical network, measurements of the electrical network may be correlated with operational parameters of the sensor. The voltage at the counter electrode provides an indication of the resistance or impedance between the working electrode and the counter electrode and is used to identify the occurrence of faults occurring at the continuous analyte monitoring device.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: January 2, 2024
    Assignee: Biolinq Incorporated
    Inventors: Joshua Ray Windmiller, Alan Steven Campbell, Jared Rylan Tangney
  • Patent number: 11672965
    Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: June 13, 2023
    Assignee: Biolinq Incorporated
    Inventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
  • Patent number: 11654270
    Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: May 23, 2023
    Assignee: Biolinq Incorporated
    Inventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner, Paul Daniel Faucher
  • Patent number: D988160
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: June 6, 2023
    Assignee: Biolinq Incorporated
    Inventor: David Morelock
  • Patent number: D996999
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: August 29, 2023
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1012744
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: January 30, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1013544
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: February 6, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1033641
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: July 2, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1035004
    Type: Grant
    Filed: February 28, 2023
    Date of Patent: July 9, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1038794
    Type: Grant
    Filed: December 7, 2023
    Date of Patent: August 13, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1051745
    Type: Grant
    Filed: April 27, 2023
    Date of Patent: November 19, 2024
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1057153
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: January 7, 2025
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock
  • Patent number: D1068516
    Type: Grant
    Filed: February 28, 2023
    Date of Patent: April 1, 2025
    Assignee: Biolinq Incorporated
    Inventor: David Michael Morelock